Enduro Genetics Secures €12M to Revolutionize Biomanufacturing by Eliminating Low-Performing Cells
Biomanufacturing is a $400 billion industry encompassing pharmaceuticals, biodegradable materials, alternative proteins, and industrial enzymes. However, a persistent challenge has hindered large-scale production: declining efficiency and poor yields. The root of the problem lies in cell mutations, which cause variations in productivity. As microorganisms prioritize survival over production, low-performing cells outcompete high-yielding ones, reducing overall […]